Literature DB >> 26109730

Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase.

Kerstin Gnirß1, Pawel Zmora1, Paulina Blazejewska1, Michael Winkler1, Anika Lins1, Inga Nehlmeier1, Sabine Gärtner1, Anna-Sophie Moldenhauer1, Heike Hofmann-Winkler1, Thorsten Wolff2, Michael Schindler3, Stefan Pöhlmann4.   

Abstract

UNLABELLED: The expression of the antiviral host cell factor tetherin is induced by interferon and can inhibit the release of enveloped viruses from infected cells. The Vpu protein of HIV-1 antagonizes the antiviral activity of tetherin, and tetherin antagonists with Vpu-like activity have been identified in other viruses. In contrast, it is incompletely understood whether tetherin inhibits influenza A virus (FLUAV) release and whether FLUAV encodes tetherin antagonists. Here, we show that release of several laboratory-adapted FLUAV strains and a seasonal FLUAV strain is inhibited by tetherin, while pandemic FLUAV A/Hamburg/4/2009 is resistant. Studies with a virus-like particle system and analysis of reassortant viruses provided evidence that the viral hemagglutinin (HA) is an important determinant of tetherin antagonism but requires the presence of its cognate neuraminidase (NA) to inhibit tetherin. Finally, tetherin antagonism by FLUAV was dependent on the virion context, since retrovirus release from tetherin-positive cells was not rescued, and correlated with an HA- and NA-dependent reduction in tetherin expression. In sum, our study identifies HA and NA proteins of certain pandemic FLUAV as tetherin antagonists, which has important implications for understanding FLUAV pathogenesis. IMPORTANCE: Influenza A virus (FLUAV) infection is responsible for substantial global morbidity and mortality, and understanding how the virus evades the immune defenses of the host may uncover novel targets for antiviral intervention. Tetherin is an antiviral effector molecule of the innate immune system which can contribute to control of viral invasion. However, it has been unclear whether FLUAV is inhibited by tetherin and whether these viruses encode tetherin-antagonizing proteins. Our observation that several pandemic FLUAV strains can counteract tetherin via their HA and NA proteins identifies these proteins as novel tetherin antagonists and indicates that HA/NA-dependent inactivation of innate defenses may contribute to the efficient spread of pandemic FLUAV.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26109730      PMCID: PMC4542344          DOI: 10.1128/JVI.00615-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses.

Authors:  Olivier Terrier; Vincent Moules; Coralie Carron; Gaëlle Cartet; Emilie Frobert; Matthieu Yver; Aurelien Traversier; Thorsten Wolff; Beatrice Riteau; Nadia Naffakh; Bruno Lina; Jean-Jacques Diaz; Manuel Rosa-Calatrava
Journal:  Virology       Date:  2012-07-06       Impact factor: 3.616

2.  Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin.

Authors:  Rie Watanabe; George P Leser; Robert A Lamb
Journal:  Virology       Date:  2011-05-28       Impact factor: 3.616

3.  Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.

Authors:  Lisa A Lopez; Su Jung Yang; Heiko Hauser; Colin M Exline; Kevin G Haworth; Jill Oldenburg; Paula M Cannon
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

4.  Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.

Authors:  Sheli R Radoshitzky; Lian Dong; Xiaoli Chi; Jeremiah C Clester; Cary Retterer; Kevin Spurgers; Jens H Kuhn; Sarah Sandwick; Gordon Ruthel; Krishna Kota; Dutch Boltz; Travis Warren; Philip J Kranzusch; Sean P J Whelan; Sina Bavari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding.

Authors:  Li Qi; John C Kash; Vivien G Dugan; Brett W Jagger; Yuk-Fai Lau; Zhong-Mei Sheng; Erika C Crouch; Kevan L Hartshorn; Jeffery K Taubenberger
Journal:  Virology       Date:  2011-02-18       Impact factor: 3.616

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

Review 7.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

8.  Gene composition of high-yielding influenza vaccine strains obtained by recombination.

Authors:  M Baez; P Palese; E D Kilbourne
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

9.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

10.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

View more
  19 in total

Review 1.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

2.  Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Authors:  Elena Heusinger; Katja Deppe; Paola Sette; Christian Krapp; Dorota Kmiec; Silvia F Kluge; Preston A Marx; Cristian Apetrei; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

3.  Early Vertebrate Evolution of the Host Restriction Factor Tetherin.

Authors:  Elena Heusinger; Silvia F Kluge; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  Antiviral Activity and Adaptive Evolution of Avian Tetherins.

Authors:  Veronika Krchlíková; Helena Fábryová; Tomáš Hron; Janet M Young; Anna Koslová; Jiří Hejnar; Klaus Strebel; Daniel Elleder
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 5.  Interplay between host non-coding RNAs and influenza viruses.

Authors:  Gayan Bamunuarachchi; Samuel Pushparaj; Lin Liu
Journal:  RNA Biol       Date:  2021-01-18       Impact factor: 4.652

6.  Host Cell Copper Transporters CTR1 and ATP7A are important for Influenza A virus replication.

Authors:  Jonathan C Rupp; Manon Locatelli; Alexis Grieser; Andrea Ramos; Patricia J Campbell; Hong Yi; John Steel; Jason L Burkhead; Eric Bortz
Journal:  Virol J       Date:  2017-01-23       Impact factor: 4.099

7.  The effect of bovine BST2A1 on the release and cell-to-cell transmission of retroviruses.

Authors:  Zhibin Liang; Yang Zhang; Jie Song; Hui Zhang; Suzhen Zhang; Yue Li; Juan Tan; Wentao Qiao
Journal:  Virol J       Date:  2017-09-06       Impact factor: 4.099

8.  Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability.

Authors:  Irene Maier; Robert H Schiestl; Georg Kontaxis
Journal:  Molecules       Date:  2021-06-13       Impact factor: 4.411

Review 9.  Host Cell Restriction Factors that Limit Influenza A Infection.

Authors:  Fernando Villalón-Letelier; Andrew G Brooks; Philippa M Saunders; Sarah L Londrigan; Patrick C Reading
Journal:  Viruses       Date:  2017-12-07       Impact factor: 5.048

Review 10.  Host Immune Response to Influenza A Virus Infection.

Authors:  Xiaoyong Chen; Shasha Liu; Mohsan Ullah Goraya; Mohamed Maarouf; Shile Huang; Ji-Long Chen
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.